Jane Street Group, LLC Kal Vista Pharmaceuticals, Inc. Transaction History
Jane Street Group, LLC
- $444 Billion
- Q4 2024
A detailed history of Jane Street Group, LLC transactions in Kal Vista Pharmaceuticals, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 69,397 shares of KALV stock, worth $839,703. This represents 0.0% of its overall portfolio holdings.
Number of Shares
69,397
Previous 20,508
238.39%
Holding current value
$839,703
Previous $237,000
147.68%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding KALV
# of Institutions
131Shares Held
53.3MCall Options Held
63.5KPut Options Held
36.6K-
Vr Adviser, LLC New York, NY6.25MShares$75.6 Million8.73% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.91MShares$59.4 Million1.73% of portfolio
-
Tang Capital Management LLC San Diego, CA4.89MShares$59.2 Million3.11% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA4.89MShares$59.1 Million2.48% of portfolio
-
Vestal Point Capital, LP New York, NY4.77MShares$57.7 Million2.4% of portfolio
About KalVista Pharmaceuticals, Inc.
- Ticker KALV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,602,000
- Market Cap $298M
- Description
- KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...